Range Cancer Therapeutics ETF (CNCR)
Explore the accurate information with month-to-month performance and year-to-date performance of Range Cancer Therapeutics ETF (CNCR) on our website. Interactive charts show its progress over time, comparing Range Cancer Therapeutics ETF (CNCR) against market indices and offering valuable insights.
Price - Range Cancer Therapeutics ETF (CNCR)
Price: $9.77CNCR - Summary Performance
3.61%
Month Performance-20.63%
Year Performance-33.81%
12 Month PerformanceCNCR - Month-to-Month Performance Over 12 Months
Check below the chart with the monthly performance of in comparison with market indices (S&P 500 / NASDAQ / NYSE / DOW JONES):
Swipe right for latest column
| ___________ | May/24 | Jun/24 | Jul/24 | Aug/24 | Sep/24 | Oct/24 | Nov/24 | Dec/24 | Jan/25 | Feb/25 | Mar/25 | Apr/25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CNCR | -1.76% | -6.86% | 13.29% | -1.44% | -0.86% | -2.47% | -1.58% | -14.22% | 0.57% | -8.04% | -17.17% | 3.61% |
| SP 500 | 4.80% | 3.47% | 1.13% | 2.28% | 2.02% | -0.99% | 5.73% | -2.50% | 2.70% | -1.42% | -5.75% | -0.91% |
| NASDAQ | 6.88% | 5.96% | -0.75% | 0.65% | 2.68% | -0.52% | 6.21% | 0.48% | 1.64% | -3.97% | -8.21% | 0.94% |
| NYSE | 2.73% | -0.32% | 3.79% | 3.11% | 1.16% | -1.42% | 5.37% | -5.80% | 4.72% | 0.15% | -3.16% | -1.58% |
| DOW JONES | 2.30% | 1.12% | 4.41% | 1.76% | 1.85% | -1.34% | 7.54% | -5.27% | 4.70% | -1.58% | -4.20% | -3.51% |
Dividend History -
Check out dividend history, dates and yield on the button below.
CNCR - Cumulative Performance in 12 Months
The chart displays the accumulated performance in 12 months, comparing with market indices.This chart shows whether has outperformed or lagged the market over the period.